Follow Us
https://www.thebody.com/category/viread-tenofovir-tdf/tag/news

The Latest

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug Img

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug

The Fair Pricing Coalition says that patients, insurers and public programs shouldn't have to pay higher costs for a next-generation HIV treatment could make combination therapy less toxic.

Promo Image

Tenofovir DF on the Horizon

A new drug application for Tenofovir disoproxil fumarate (Tenofovir DF) has been filed with the Food and Drug Administration by Gilead Sciences. Tenofovir DF, also known as PMPA, could be approved within the next six months.

Tenofovir DF is an inves...

Promo Image

Tenofovir: FDA Hearing October 3, Public Comment Deadlines September 26

On October 3 the FDA's Antiviral Drugs Advisory Committee will hold a public hearing on tenofovir (full chemical name tenofovir disoproxil fumarate, or tenofovir DF; new brand name Viread™, an antiretroviral developed by Gilead Sciences and currently...

Promo Image

Tenofovir: Gilead Applies for Approval; Expanded Access Liberalized

Tenofovir, Gilead Sciences' candidate reverse transcriptase inhibitor, could be approved in about six months. In an unexpected move, the company announced May 1 that it had filed a New Drug Application with the FDA. After approval, tenofovir could be...

Promo Image

PMPA: Experimental Drug That Completely Protects Monkeys Exposed to SIV

This is a statement from the National Institutes of Health (NIH) concerning an experimental drug that completely protects monkeys exposed to SIV.

An experimental drug called PMPA given to 25 macaque monkeys up to a day after they were exposed to sim...